Skip to main content
ODTX
NASDAQ Life Sciences

Odyssey Therapeutics Secures $25M Private Placement Concurrent with IPO

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$17.45
Mkt Cap
--
52W Low
$16.405
52W High
$17.72
52W Position info
6.4% above low
Off High info
1.5% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ODTX is trading near its 52-week low of $16.405 (6.4% above the low).

Summary

Odyssey Therapeutics completed a $25 million private placement with TPG at its IPO price, bolstering its capital position as it transitions to a public company.


Key Events · Financing and Capital Events · ODTX

  • Private Placement Completed

    Odyssey Therapeutics sold 1,388,889 shares of common stock to TPG LSI Rise Orazio II, L.P., an affiliate of an existing stockholder, for a total of $25,000,002.

  • Pricing at IPO Level

    The shares were sold at $18.00 per share, matching the initial public offering price and representing a premium to the current market price of $17.45.

  • Concurrent with IPO

    The private placement closed concurrently with the company's initial public offering, providing additional capital as the company went public.

  • Corporate Governance Established

    The company filed an amended and restated certificate of incorporation and adopted amended and restated bylaws, effective May 11, 2026, in connection with its IPO.


Analysis · ODTX · Life Sciences

This filing details a significant $25 million private placement of common stock to an affiliate of an existing institutional stockholder, TPG, at the initial public offering price of $18.00 per share. This transaction closed concurrently with the company's IPO, providing additional capital and demonstrating strong institutional support for the newly public entity. The private placement price is also at a premium to the current market price of $17.45. The filing also includes standard amendments to the company's corporate charter and bylaws, establishing the governance framework for a public company.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ODTX was trading at $17.45 on NASDAQ in the Life Sciences sector. The 52-week trading range was $16.41 to $17.72. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ODTX - Latest Insights

ODTX
Nov 04, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $21.57
Real-time Price: $19.36 info
Change: -$2.21 (-10%) info
Market Cap: $930.594M info
ODTX
Nov 04, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.57
Real-time Price: $19.36 info
Change: -$2.21 (-10%) info
Market Cap: $930.594M info
ODTX
Oct 20, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.10
Real-time Price: $19.36 info
Change: +$1.26 (+7%) info
Market Cap: $930.594M info
ODTX
Oct 20, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $17.80
Real-time Price: $19.36 info
Change: +$1.56 (+9%) info
Market Cap: $930.594M info
ODTX
Sep 08, 2026, 7:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.97
Real-time Price: $19.36 info
Change: -$7.61 (-28%) info
Market Cap: $930.594M info